PubRank

Ian A Greer

Author PubWeight™ 69.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 4.50
2 Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 2002 3.96
3 Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008 3.81
4 Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007 3.67
5 Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 2002 2.80
6 Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol Hum Reprod 2003 2.47
7 Manifestations of chronic disease during pregnancy. JAMA 2005 2.06
8 Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab 2006 1.97
9 Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 2004 1.92
10 Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis 2004 1.66
11 The potential role of heparin in assisted conception. Hum Reprod Update 2008 1.62
12 Paradoxical elevation in adiponectin concentrations in women with preeclampsia. Hypertension 2003 1.60
13 Changes in booking body mass index over a decade: retrospective analysis from a Glasgow Maternity Hospital. BJOG 2005 1.55
14 Immunolocalization of proinflammatory cytokines in myometrium, cervix, and fetal membranes during human parturition at term. Biol Reprod 2002 1.54
15 Cost-effectiveness of screening for the factor V Leiden mutation in pregnant women. Lancet 2002 1.47
16 SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood 2010 1.40
17 Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 1.39
18 Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol 2012 1.34
19 Classic and novel risk factor parameters in women with a history of preeclampsia. Hypertension 2003 1.33
20 Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J Clin Endocrinol Metab 2002 1.28
21 Inverse association between birth weight and C-reactive protein concentrations in the MIDSPAN Family Study. Arterioscler Thromb Vasc Biol 2004 1.26
22 Microvascular dysfunction: a link between pre-eclampsia and maternal coronary heart disease. BJOG 2003 1.12
23 The "PRIM" study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. Am J Obstet Gynecol 2006 1.11
24 The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies. PLoS Med 2010 1.05
25 Leukocyte density and proinflammatory mediator expression in regional human fetal membranes and decidua before and during labor at term. J Soc Gynecol Investig 2006 1.04
26 Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 2006 1.04
27 Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thromb Haemost 2005 1.01
28 Longitudinal assessment of erythrocyte fatty acid composition throughout pregnancy and post partum. Lipids 2007 0.96
29 Elimination of electrically induced iontophoretic artefacts: implications for non-invasive assessment of peripheral microvascular function. J Vasc Res 2002 0.94
30 The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes. Br J Haematol 2007 0.93
31 Microvascular function, metabolic syndrome, and novel risk factor status in women with cardiac syndrome X. Am J Cardiol 2006 0.92
32 Chemokine scavenger D6 is expressed by trophoblasts and aids the survival of mouse embryos transferred into allogeneic recipients. J Immunol 2010 0.92
33 The impact of guidelines on mild hypertension in pregnancy: time series analysis. BJOG 2004 0.87
34 Human placental peroxisome proliferator-activated receptor delta and gamma expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction. J Soc Gynecol Investig 2005 0.87
35 Divergent metabolic and vascular phenotypes in pre-eclampsia and intrauterine growth restriction: relevance of adiposity. J Hypertens 2004 0.86
36 Preeclampsia is associated with compromised maternal synthesis of long-chain polyunsaturated fatty acids, leading to offspring deficiency. Hypertension 2012 0.85
37 Is screening for thrombophilia cost-effective? Curr Opin Hematol 2007 0.81
38 Pre-eclampsia matters. BMJ 2005 0.81
39 Vascular dysfunction and alteration of novel and classic cardiovascular risk factors in mothers of growth restricted offspring. Atherosclerosis 2008 0.81
40 Prevention and treatment of arterial thrombosis in pregnancy. Semin Thromb Hemost 2003 0.80
41 Enhancement of endothelial function by pregnancy: inadequate response in women with type 1 diabetes. Diabetes Care 2003 0.80
42 Thrombophilia and the risk for venous thromboembolism during pregnancy, delivery, and puerperium. Obstet Gynecol Clin North Am 2006 0.79
43 Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated by thrombin in human monocytes and THP-1 cells in vitro and in pregnant subjects in vivo. Thromb Haemost 2003 0.79
44 Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). BMC Geriatr 2011 0.78
45 Anticoagulation with Tinzaparin for women with mechanical valves in pregnancy: a retrospective case series. Thromb Res 2012 0.78
46 Outcomes of pregnancy complicated by thyroid disease. Aust N Z J Obstet Gynaecol 2005 0.77
47 Supraphysiological concentrations of estradiol in menopausal women given repeated implant therapy do not adversely affect lipid profiles. Hum Reprod 2002 0.77
48 Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? Clin Endocrinol (Oxf) 2003 0.76
49 Tinzaparin use in pregnancy: an international, retrospective study of the safety and efficacy profile. Eur J Obstet Gynecol Reprod Biol 2011 0.75
50 Endothelial cell microparticles and antiphospholipid syndrome: pathologic explanations and diagnostic opportunities. Thromb Haemost 2004 0.75
51 A population-based study of venous thrombosis in pregnancy in Scotland 1980-2005. Eur J Obstet Gynecol Reprod Biol 2013 0.75
52 Venous thrombosis prevention - more than just guidelines. Br J Haematol 2010 0.75
53 Statins as novel therapies for osteoporosis? Eur J Obstet Gynecol Reprod Biol 2002 0.75
54 CLINICAL PRACTICE. Pregnancy Complicated by Venous Thrombosis. N Engl J Med 2015 0.75
55 Thromboembolic events in pregnancy: pharmacological prophylaxis and treatment. Expert Opin Pharmacother 2007 0.75
56 The G-to-T point mutation in codon 34 of the factor XIII gene and the risk of pre-eclampsia. Blood Coagul Fibrinolysis 2003 0.75
57 Hypertensive disorders of pregnancy: preventative-, immediate- and long-term management. Expert Rev Pharmacoecon Outcomes Res 2006 0.75